Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Nemunaitis, J.
84  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

Clonal Neoantigen: Emerging "Mechanism-based" Biomarker of ..:

Nemunaitis, J ; Stanbery, L ; Willoughby, D...
Nemunaitis, J.; Stanbery, L.; Willoughby, D.; Bognar, E.; Brun, S.; Walter, A.; Monk, B.J.; Rocconi, R.P.; Choucair, K.; Coleman, R.L. Clonal Neoantigen: Emerging "Mechanism-based" Biomarker of Immunotherapy Response. Cancers 2023, 15, 5616. https://doi.org/10.3390/cancers15235616.  , 2023
Link: http://hdl.handle.net/10..
 
?
2

Intrigue: Phase III study of ripretinib versus sunitinib in..:

Nemunaitis, J ; Bauer, S ; Blay, J-Y...
issn:1479-6694.  , 2020
Link: http://hdl.handle.net/11..
 
?
3

A Randomized Phase II Trial of Epigenetic Priming with Guad..:

Oza, AM ; Matulonis, UA ; Alvarez Secord, A...
https://discovery.ucl.ac.uk/id/eprint/10092744/1/Guadecitabine%20and%20carboplatin%20in%20ovarian%20cancer.pdf.  , 2020
Link: https://discovery.ucl.ac..
 
?
4

Clinical Activity, Tolerability, and Long-Term Follow-Up of..:

Antonia S ; Balmanoukian A ; Brahmer J...
info:eu-repo/semantics/altIdentifier/pmid/31228626.  , 2019
Link: https://hdl.handle.net/1..
 
?
5

First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-..:

Munster P ; Mita M ; Mahipal A...
https://www.dovepress.com/first-in-human-phase-i-study-of-a-dual-mtor-kinase-and-dna-pk-inhibito-peer-reviewed-article-CMAR.  , 2019
Link: https://doaj.org/article..
 
?
6

Metformin Restrains Pancreatic Duodenal Homeobox-1 (PDX-1) ..:

Zhou, G ; Yu, J ; Wang, A...
qt1xf4v083.  , 2016
Link: https://escholarship.org..
 
?
7

Evofosfamide for the treatment of human papillomavirus-nega..:

Jamieson, Stephen MF ; Tsai, Peter ; Kondratyev, Maria K...
JCI insight.  , 2024
Link: https://hdl.handle.net/2..
 
?
8

Safety and Efficacy of Pembrolizumab in Combination with Ac..:

Taylor, Matthew H ; Betts, Courtney B ; Maloney, Lauren...
qt6jr8p2bh.  , 2022
Link: https://escholarship.org..
 
?
9

Phase I Open-Label Study Evaluating the Safety, Pharmacokin..:

Gordon, Michael S ; Nemunaitis, John ; Barve, Minal...
qt1928592v.  , 2021
Link: https://escholarship.org..
 
?
10

Repurposing metformin, simvastatin and digoxin as a combina..:

Liu, Shi-He ; Yu, Juehua ; Creeden, Justin F...
qt8v09n9d0.  , 2020
Link: https://escholarship.org..
 
?
11

Avelumab in patients with previously treated metastatic mel..:

Keilholz, Ulrich ; Mehnert, Janice M ; Bauer, Sebastian...
Journal for ImmunoTherapy of Cancer, 7(1):12.  , 2019
Link: https://hdl.handle.net/1..
 
?
12

A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (..:

Wolin, Edward ; Mita, Alain ; Mahipal, Amit...
qt9c61n8fd.  , 2019
Link: https://escholarship.org..
 
?
13

Clinical Activity, Tolerability, and Long-Term Follow-Up of..:

Antonia, Scott J ; Balmanoukian, Ani ; Brahmer, Julie...
Journal of Thoracic Oncology, Vol.14 No.10, pp.1794-1806.  , 2019
Link: http://hdl.handle.net/10..
 
?
14

First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-..:

Munster, Pamela ; Mita, Monica ; Mahipal, Amit...
qt0ct845jv.  , 2019
Link: https://escholarship.org..
 
?
15

A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (..:

Wolin, Edward ; Mita, Alain ; Mahipal, Amit...
https://doi.org/10.1371/journal.pone.0221994..  , 2019
Link: https://hdl.handle.net/2..
 
1-15